Navigation Links
Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz
Date:12/11/2008

TUSTIN, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that Thomas A. Waltz, M.D., chairman of its Board of Directors, unexpectedly passed away on Wednesday. Dr. Waltz had been a director of Peregrine since 2004 and was chairman since 2005. At the time of his death, Dr. Waltz served on Peregrine's Audit Committee, Compensation Committee and Nominating Committee.

"The sudden loss of our business colleague and friend Tom Waltz brings sadness to the entire Peregrine family," said Steven W. King, president and CEO of Peregrine. "Our deepest sympathies go out to Tom's family and to all who knew him well. Tom's distinguished career as a top neurosurgeon and healthcare executive was matched by his generosity and spirit. His medical and healthcare expertise was of significant value to Peregrine and his talents, wisdom and guidance will be missed."

Dr. Waltz was a neurosurgeon and a senior consultant in Neurosurgery at the Scripps Clinic in La Jolla, California. He formerly was chairman and CEO of the Scripps Clinic and president of the Scripps Clinic Medical Group. Dr. Waltz also served on the Board of Genoptix Inc. and Premera Blue Cross of Washington and Alaska. He received his undergraduate degree from the University of Cincinnati, his M.D. from Vanderbilt University and his neurosurgical training at Baylor College of Medicine. Dr. Waltz also had training in Neurology at The National Hospital for Neurological Diseases and in Neuropathology at Oxford University, both in the U.K.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C vir
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Peregrine Pharmaceuticals Enters Into a Loan Agreement for up to $10 Million
2. Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results
3. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
4. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
5. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
6. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
7. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
8. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
9. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
10. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
11. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- Research and Markets  has announced the addition of the ... report to their offering. This report analyzes ... Thousands by the following Product Segments: Media, Sera, and Reagents. ... Canada , Japan , ... Latin America . Annual estimates and forecasts are provided for ...
(Date:8/19/2014)... Cellgen Diagnostics today launched ... a corporate lab for its genetic-based medical testing ... a critical component in the move from today’s ... of personalized medicine – a more predictive, preventive, ... contributions will support Cellgen’s intent to develop the ...
(Date:8/19/2014)... 19, 2014 Robin Williams’ passing is ... take on an individual. Symptoms range from slowness ... problems swallowing and severe depression. Parkinson’s disease progressively ... of dopamine producing neurons of the brain. As ... that slowly and progressively gets worse, they look for ...
(Date:8/19/2014)... 19, 2014 Research and ... the "Spectroscopy Equipment and Accessories - ... their offering. This report ... and Accessories in US$ Thousands by the ... Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared (NIR) ...
Breaking Biology Technology:Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2
... worked for almost seven years in secret. , Most ... Goehner,s materials characterization department at Sandia National Laboratories was ... containing bacillus anthracis, the spores that cause the disease ... 2001 to several news media offices and to two ...
... in the nanocrystals of semiconductors to cool more slowly ... the potential to improve satellite communications and the generation ... these electronsin this case, by more than 30 timescould ... Guyot-Sionnest, Professor of Chemistry and Physics at the University ...
... Nov. 13 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... &,Company, LLC,s Focus on Infectious Disease Conference on Thursday, ... at the Needham and Company,LLC,s office in New York ... Officer of Anadys,will present an overview of Anadys and ...
Cached Biology Technology:FBI unveils science of anthrax investigation 2FBI unveils science of anthrax investigation 3New research expected to improve laser devices and make photovoltaics more efficient 2Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference 2
(Date:8/19/2014)... KNOXVILLEToday,s students in college biology and other science ... in quantitative ways, and now they have a ... for the Life Sciences," published this month by ... National Institute for Mathematical and Biological Synthesis (NIMBioS), ... that can be used to explore and explain ...
(Date:8/19/2014)... A team of UTSA researchers has been awarded a ... Technology and Training (NCPTT), an office of the National ... The grant will fund a one-year study of the ... of historic homes in hot, humid climates. , Radiant ... or attics that reflect heat back, thereby reducing the ...
(Date:8/19/2014)... to humans and animals in a number of ways. ... them to regrow entire organs. After being struck by ... entire crown. But there is one major downside to ... to the habitats in which they live and therefore ... to this dilemma, plants have developed mechanisms that enable ...
Breaking Biology News(10 mins):New textbook introduces undergraduates to mathematics for the life sciences 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3How steroid hormones enable plants to grow 2
... million people in 36 countries of sub-Saharan Africa are ... African sleeping sickness. The disease is caused by organisms ... African sleeping sickness affects approximately 500,000 people in sub-Saharan ... Because the trypanosome has an exceptional genetic strategy for ...
... headed by Professor Hans-Georg Kräusslich at Heidelberg University ... Applied Tumor Virology of the Deutsches Krebsforschungszentrum (German ... to label Human Immunodeficiency Viruses (HIV) for visual ... virus. , The labeling permits scientists to observe ...
... virologists headed by Professor Hans-Georg Kräusslich at Heidelberg ... of Applied Tumor Virology of the Deutsches Krebsforschungszentrum ... first to label Human Immunodeficiency Viruses (HIV) for ... the virus. , The labeling permits scientists to ...
Cached Biology News:Newly discovered protein an important tool for sleeping sickness research 2New Species of Coral Discovered Off Southern California 2Virologists make major step towards understanding the process of HIV infection 2
... TriEx Sf9 Cells and TriEx Insect Cell ... pTriEx baculovirus constructs. This cell/medium combination has ... growth and high protein expression levels observed ... vectors. Please note that our Ready-Plaque Sf9 ...
...
...
...
Biology Products: